Doxorubicin-An Agent with Multiple Mechanisms of Anticancer Activity

被引：361

作者：

Kciuk, Mateusz ^{[1
,2
]}

Gielecinska, Adrianna ^{[1
,2
]}

Mujwar, Somdutt ^{[3
]}

Kolat, Damian ^{[4
]}

Kaluzinska-Kolat, Zaneta ^{[4
]}

Celik, Ismail ^{[5
]}

Kontek, Renata ^{[1
]}

机构：

[1] Univ Lodz, Dept Mol Biotechnol & Genet, PL-90237 Lodz, Poland

[2] Univ Lodz, Doctoral Sch Exact & Nat Sci, PL-90237 Lodz, Poland

[3] Chitkara Univ, Chitkara Coll Pharm, Rajpura 140401, Punjab, India

[4] Med Univ Lodz, Fac Med, Dept Expt Surg, PL-90136 Lodz, Poland

[5] Erciyes Univ, Fac Pharm, Dept Pharmaceut Chem, TR-38039 Kayseri, Turkiye

来源：

CELLS | 2023年 / 12卷 / 04期

关键词：

adriamycin; apoptosis; DNA damage response (DDR); doxorubicin; immunotherapy; PEGYLATED-LIPOSOMAL DOXORUBICIN; CELL-CYCLE ARREST; STRAND BREAK REPAIR; DNA-DAMAGE RESPONSE; OXYGEN SPECIES ROS; LIGAND; EXPRESSION; UP-REGULATION; OXIDATIVE STRESS; DRUG-DELIVERY; MRN COMPLEX;

D O I：

10.3390/cells12040659

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Doxorubicin (DOX) constitutes the major constituent of anti-cancer treatment regimens currently in clinical use. However, the precise mechanisms of DOX's action are not fully understood. Emerging evidence points to the pleiotropic anticancer activity of DOX, including its contribution to DNA damage, reactive oxygen species (ROS) production, apoptosis, senescence, autophagy, ferroptosis, and pyroptosis induction, as well as its immunomodulatory role. This review aims to collect information on the anticancer mechanisms of DOX as well as its influence on anti-tumor immune response, providing a rationale behind the importance of DOX in modern cancer therapy.

引用

页数：30

共 279 条

[1] Coordination of DNA single strand break repair [J].

Abbotts, Rachel ;

Wilson, David M., III .

FREE RADICAL BIOLOGY AND MEDICINE, 2017, 107 :228-244

[2] Liposome: classification, preparation, and applications [J].

Akbarzadeh, Abolfazl ;

Rezaei-Sadabady, Rogaie ;

Davaran, Soodabeh ;

Joo, Sang Woo ;

Zarghami, Nosratollah ;

Hanifehpour, Younes ;

Samiei, Mohammad ;

Kouhi, Mohammad ;

Nejati-Koshki, Kazem .

NANOSCALE RESEARCH LETTERS, 2013, 8

[3] Matrix metalloproteinase-activated doxorubicin prodrugs inhibit HT1080 xenograft growth doxorubicin with less toxicity [J].

Albright, CF ;

Graciani, N ;

Han, W ;

Yue, E ;

Stein, R ;

Lai, ZH ;

Diamond, M ;

Dowling, R ;

Grimminger, L ;

Zhang, SY ;

Behrens, D ;

Musselman, A ;

Bruckner, R ;

Zhang, MZ ;

Jiang, X ;

Hu, D ;

Higley, A ;

DiMeo, S ;

Rafalski, M ;

Mandlekar, S ;

Car, B ;

Yeleswaram, S ;

Stern, A ;

Copeland, RA ;

Combs, A ;

Seitz, SP ;

Trainor, GL ;

Taub, R ;

Huang, P ;

Oliff, A .

MOLECULAR CANCER THERAPEUTICS, 2005, 4 (05) :751-760

[4] Doxorubicin-induced neurotoxicity is associated with acute alterations in synaptic plasticity, apoptosis, and lipid peroxidation [J].

Alhowail, Ahmad H. ;

Bloemer, Jenna ;

Majrashi, Mohammed ;

Pinky, Priyanka D. ;

Bhattacharya, Subhrajit ;

Zhang Yongli ;

Bhattacharya, Dwipayan ;

Eggert, Matthew ;

Woodie, Lauren ;

Buabeid, Manal A. ;

Johnson, Nathaniel ;

Broadwater, Alyssa ;

Smith, Bruce ;

Dhanasekaran, Muralikrishnan ;

Arnold, Robert D. ;

Suppiramaniam, Vishnu .

TOXICOLOGY MECHANISMS AND METHODS, 2019, 29 (06) :457-466

[5] Cyclin-dependent kinase inhibitors (CDKIs) and the DNA damage response: The link between signaling pathways and cancer [J].

Amani, Jafar ;

Gorjizadeh, Nassim ;

Younesi, Simin ;

Najafi, Mojtaba ;

Ashrafi, Arash M. ;

Irian, Saeed ;

Gorjizadeh, Negar ;

Azizian, Khalil .

DNA REPAIR, 2021, 102

[6] The most prevalent side effects of pegylated liposomal doxorubicin monotherapy in women with metastatic breast cancer: a systematic review of clinical trials [J].

Ansari, L. ;

Shiehzadeh, F. ;

Taherzadeh, Z. ;

Nikoofal-Sahlabadi, S. ;

Momtazi-Borojeni, A. A. ;

Sahebkar, A. ;

Eslami, S. .

CANCER GENE THERAPY, 2017, 24 (05) :189-193

[7] Endogenous aldehyde accumulation generates genotoxicity and exhaled biomarkers in esophageal adenocarcinoma [J].

Antonowicz, Stefan ;

Bodai, Zsolt ;

Wiggins, Tom ;

Markar, Sheraz R. ;

Boshier, Piers R. ;

Goh, Yan Mei ;

Adam, Mina E. ;

Lu, Haonan ;

Kudo, Hiromi ;

Rosini, Francesca ;

Goldin, Robert ;

Moralli, Daniela ;

Green, Catherine M. ;

Peters, Chris J. ;

Habib, Nagy ;

Gabra, Hani ;

Fitzgerald, Rebecca C. ;

Takats, Zoltan ;

Hanna, George B. .

NATURE COMMUNICATIONS, 2021, 12 (01)

[8] The Determining Role of Mitochondrial Reactive Oxygen Species Generation and Monoamine Oxidase Activity in Doxorubicin-Induced Cardiotoxicity [J].

Antonucci, Salvatore ;

Di Sante, Moises ;

Tonolo, Federica ;

Pontarollo, Laura ;

Scalcon, Valeria ;

Alanova, Petra ;

Menabo, Roberta ;

Carpi, Andrea ;

Bindoli, Alberto ;

Rigobello, Maria Pia ;

Giorgio, Marco ;

Kaludercic, Nina ;

Di Lisa, Fabio .

ANTIOXIDANTS & REDOX SIGNALING, 2021, 34 (07) :531-550

[9] Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity [J].

Aries, A ;

Paradis, P ;

Lefebvre, C ;

Schwartz, RJ ;

Nemer, M .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (18) :6975-6980

[10] Toxicity of Doxorubicin (Dox) to different experimental organ systems [J].

Arivalagan Pugazhendhi ;

Edison, Thomas Nesakumar Jebakumar Immanuel ;

Velmurugan, Bharath Kumar ;

Jacob, Joe Antony ;

Karuppusamy, Indira .

LIFE SCIENCES, 2018, 200 :26-30

← 1 2 3 4 5 6 7 8 9 10 →